Webinar hosted by DWS: Faecal Microbiota Transplantation and the Clinical Potential of the Human Microbiome

Got a Question? Request a Callback

Faecal Microbiota Transplantation and the Clinical Potential of the Human Microbiome

Don Whitley Scientific is pleased to present ‘Faecal Microbiota Transplantation and the Clinical Potential of the Human Microbiome’, scheduled for 23rd November 2022 at 9:00-11:00 (GMT). The webinar will feature three international speakers and is free to attend!

After the success of our microbiome webinar earlier this year we cannot wait to share a variety of insightful information from specialists within the field of FMT.

Dr Jannie G E Henderickx

Centre for Microbiome Analyses and Therapeutics, Leiden University Medical Centre

Multi-kingdom interactions in Clostridioides difficile colonization and infection

Dr. Jannie G.E. Henderickx is a postdoctoral researcher and study coordinator at the Centre for Microbiome Analyses and Therapeutics (CMAT) at Leiden University Medical Centre. Jannie performed her PhD research at the Microbiology department of Wageningen University & Research, investigating the early life microbiome of preterm infants. Within her current research, Jannie aims to uncover the human microbiome’s clinical potential. Bioinformatic approaches allow her to study the ecology and functions of bacteria and fungi constituting the human microbiome in a wide spectrum of disease states.

Chelsea Bickley 

BiomeBank, Adelaide, South Australia

Anaerobic manufacturing of first-in-class microbiome drug product

Chelsea Bickley has always been passionate about helping people through science ever since she was young. In 2010 she completed her studies at Flinders University in Adelaide Australia, with a major in Biochemistry and an Honours degree. After a few years in the workforce, she joined CSIRO in the middle of 2014 and was there for several years. During her time at CSIRO she met one of the founders of BiomeBank, Sam Costello and assisted in the lab-work for his PhD on FMT for the treatment of Ulcerative Colitis igniting her interest in the field. After her time at CSIRO ended, she joined BiomeBank and has been there since 2020 and assumed the Head of Production title in 2021.

Dr Andrea Aira Gómez

Department of Clinical Microbiology, Hospital Clinic of Barcelona

Optimization of stool processing to maximize the efficacy of FMT treatments

Dr Andrea Gómez is a microbiologist, PhD in Medicine and Translational research with experience in FMT implementation in clinical settings including stool donor selection, sample processing and stool banking.

Register today!


Choose a Country

If you are based in Germany or Australia, please select the website of our subsidiary company there. A different selection of products is available in these countries. Otherwise, please select ‘English’ and you will be able to find your local distributor in the ‘Overseas Distributors’ section.

Share this

Please select your preferred language from the list below


Don't have an account? Click Here

Forgot your password? Click Here